Eurobio Scientific Société anonyme (ALERS.PA)
EUR 25.3
(1.2%)
EUR 25.3
(1.2%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 21.44 Million EUR | -0.95% |
| 2022 | 21.65 Million EUR | 32.91% |
| 2021 | 16.29 Million EUR | 26.03% |
| 2020 | 12.92 Million EUR | 45.35% |
| 2019 | 8.89 Million EUR | -3.66% |
| 2018 | 9.23 Million EUR | 25.97% |
| 2017 | 7.32 Million EUR | 236.66% |
| 2016 | 2.17 Million EUR | 6.14% |
| 2015 | 2.05 Million EUR | 2.14% |
| 2014 | 2 Million EUR | 35.68% |
| 2013 | 1.48 Million EUR | -18.73% |
| 2012 | 1.82 Million EUR | 797.04% |
| 2011 | 203 Thousand EUR | 4.1% |
| 2010 | 195 Thousand EUR | 13.37% |
| 2009 | 172 Thousand EUR | -2.82% |
| 2008 | 177 Thousand EUR | 180.95% |
| 2007 | 63 Thousand EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 23.43 Million EUR | 0.0% |
| 2023 Q2 | 36.65 Million EUR | 0.0% |
| 2023 FY | 21.44 Million EUR | -0.95% |
| 2023 Q4 | 21.44 Million EUR | 0.0% |
| 2022 Q4 | 21.65 Million EUR | 0.0% |
| 2022 FY | 21.65 Million EUR | 32.91% |
| 2022 Q2 | 18.94 Million EUR | 0.0% |
| 2021 Q4 | 16.29 Million EUR | 0.0% |
| 2021 FY | 16.29 Million EUR | 26.03% |
| 2021 Q2 | 14.69 Million EUR | 0.0% |
| 2020 FY | 12.92 Million EUR | 45.35% |
| 2020 Q4 | 12.92 Million EUR | 0.0% |
| 2020 Q2 | 12.4 Million EUR | 0.0% |
| 2019 Q2 | 7.83 Million EUR | 0.0% |
| 2019 Q4 | 8.89 Million EUR | 0.0% |
| 2019 FY | 8.89 Million EUR | -3.66% |
| 2018 Q4 | 9.23 Million EUR | 0.0% |
| 2018 FY | 9.23 Million EUR | 25.97% |
| 2018 Q2 | 6.58 Million EUR | 0.0% |
| 2017 Q4 | 7.32 Million EUR | 0.0% |
| 2017 FY | 7.32 Million EUR | 236.66% |
| 2017 Q2 | 5.11 Million EUR | 0.0% |
| 2016 Q4 | 2.17 Million EUR | 0.0% |
| 2016 Q2 | 1.71 Million EUR | 0.0% |
| 2016 FY | 2.17 Million EUR | 6.14% |
| 2015 FY | 2.05 Million EUR | 2.14% |
| 2015 Q4 | 2.05 Million EUR | 0.0% |
| 2015 Q2 | 2.41 Million EUR | 0.0% |
| 2014 Q4 | 2 Million EUR | 0.0% |
| 2014 FY | 2 Million EUR | 35.68% |
| 2014 Q2 | 1.42 Million EUR | 0.0% |
| 2013 Q2 | 1.3 Million EUR | 0.0% |
| 2013 FY | 1.48 Million EUR | -18.73% |
| 2013 Q4 | 1.48 Million EUR | 0.0% |
| 2012 Q4 | 1.82 Million EUR | 300.0% |
| 2012 Q1 | 455.25 Thousand EUR | 124.26% |
| 2012 FY | 1.82 Million EUR | 797.04% |
| 2012 Q2 | 147 Thousand EUR | -67.71% |
| 2012 Q3 | 455.25 Thousand EUR | 209.69% |
| 2011 Q1 | 50.75 Thousand EUR | -73.97% |
| 2011 FY | 203 Thousand EUR | 4.1% |
| 2011 Q4 | 203 Thousand EUR | 300.0% |
| 2011 Q3 | 50.75 Thousand EUR | -60.96% |
| 2011 Q2 | 130 Thousand EUR | 156.16% |
| 2010 Q1 | 48.75 Thousand EUR | -71.66% |
| 2010 Q2 | 180 Thousand EUR | 269.23% |
| 2010 Q3 | 48.75 Thousand EUR | -72.92% |
| 2010 Q4 | 195 Thousand EUR | 300.0% |
| 2010 FY | 195 Thousand EUR | 13.37% |
| 2009 Q4 | 172 Thousand EUR | 300.0% |
| 2009 Q3 | 43 Thousand EUR | 0.0% |
| 2009 Q2 | 43 Thousand EUR | 0.0% |
| 2009 Q1 | 43 Thousand EUR | -2.82% |
| 2009 FY | 172 Thousand EUR | -2.82% |
| 2008 Q3 | 44.25 Thousand EUR | 0.0% |
| 2008 Q1 | 44.25 Thousand EUR | 180.95% |
| 2008 Q2 | 44.25 Thousand EUR | 0.0% |
| 2008 FY | 177 Thousand EUR | 180.95% |
| 2008 Q4 | 44.25 Thousand EUR | 0.0% |
| 2007 Q2 | 15.75 Thousand EUR | 0.0% |
| 2007 FY | 63 Thousand EUR | 0.0% |
| 2007 Q1 | 15.75 Thousand EUR | 0.0% |
| 2007 Q4 | 15.75 Thousand EUR | 0.0% |
| 2007 Q3 | 15.75 Thousand EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Affluent Medical SA | - EUR | -Infinity% |
| Bluelinea Société Anonyme | 236.08 Thousand EUR | -8985.21% |
| Carmat SA | 23.94 Million EUR | 10.42% |
| Diagnostic Medical Systems S.A. | 16.04 Million EUR | -33.722% |
| Euromedis Groupe | 10.8 Million EUR | -98.465% |
| Ikonisys S.A. | 473.37 Thousand EUR | -4431.042% |
| Implanet S.A. | 3.78 Million EUR | -467.434% |
| Median Technologies SA | 102 Thousand EUR | -20928.431% |
| SpineGuard SA | 950.88 Thousand EUR | -2155.693% |
| Theraclion SA | 3.05 Million EUR | -602.162% |
| Euroapi S.A. | 644.8 Million EUR | 96.674% |
| Guerbet SA | 309.51 Million EUR | 93.07% |